Martin A. Lehr insider trades
Open-market stock purchases and sales by Martin A. Lehr, Chief Executive Officer at Context Therapeutics Inc, from SEC Form 4 filings since Oct 22, 2021.
Track record: 0% of 12 scored buys are up 5% or more since purchase, averaging -77%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 19, 2026 | CNTX Context Therapeutics Inc | Bought (not open market) | — |
Companies traded
- CNTX Context Therapeutics Inc: 12 buys, last Feb 19, 2026